PriceTargets.com logo

Amplifon - AMFPF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $30.50
  • Forecasted Upside: 59.60%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$19.11 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for AMFPF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Amplifon Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMFPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMFPF

Analyst Price Target is $30.50
▲ +59.60% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Amplifon in the last 3 months. The average price target is $30.50, with a high forecast of $33.00 and a low forecast of $28.00. The average price target represents a 59.60% upside from the last price of $19.11.

This chart shows the closing price for AMFPF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 polled investment analysts is to buy stock in Amplifon. This rating has held steady since August 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/25/2023Jefferies Financial GroupUpgradeHold ➝ Buy
11/22/2022BarclaysBoost Target€30.00 ➝ €33.00
10/28/2022Morgan StanleyLower Target€29.00 ➝ €28.00
10/18/2022Morgan StanleyInitiated CoverageEqual Weight
9/13/2022BarclaysInitiated CoverageOverweight
7/27/2022Oddo BhfUpgradeNeutral ➝ Outperform
3/31/2022JPMorgan Chase & Co.Initiated CoverageNeutral
11/2/2021Morgan StanleyReiterated RatingEqual Weight
9/14/2021Kepler Capital MarketsDowngradeBuy ➝ Hold
6/8/2021Morgan StanleyReiterated RatingEqual Weight
12/9/2020Morgan StanleyReiterated RatingEqual Weight
11/19/2020Stifel NicolausDowngradeBuy ➝ Hold
10/8/2020CitigroupInitiated CoverageBuy
4/9/2020Jefferies Financial GroupReiterated RatingHold
9/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 3/26/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Amplifon logo
Amplifon SpA is engaged in the distribution, application, and customization of hearing solutions. It contributes to the development of detection and rehabilitation techniques in otology diagnosis, and management of computerized and integrated auditory systems. The firm operates through the following geographical segments: Europe, Middle East and Africa (EMEA); Americas; and Asia-Pacific. The company was founded by Algernon Charles Holland in 1950 and is headquartered in Milan, Italy.
Read More

Today's Range

Now: $19.11
Low: $19.11
High: $19.11

50 Day Range

MA: $21.23
Low: $19.11
High: $25.00

52 Week Range

Now: $19.11
Low: $19.11
High: $43.55

Volume

N/A

Average Volume

3 shs

Market Capitalization

$4.33 billion

P/E Ratio

20.55

Dividend Yield

N/A

Beta

0.56

Frequently Asked Questions

What sell-side analysts currently cover shares of Amplifon?

The following Wall Street analysts have issued stock ratings on Amplifon in the last year: Barclays PLC, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, and Oddo Bhf.
View the latest analyst ratings for AMFPF.

What is the current price target for Amplifon?

2 Wall Street analysts have set twelve-month price targets for Amplifon in the last year. Their average twelve-month price target is $30.50, suggesting a possible upside of 59.6%. Barclays PLC has the highest price target set, predicting AMFPF will reach $33.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $28.00 for Amplifon in the next year.
View the latest price targets for AMFPF.

What is the current consensus analyst rating for Amplifon?

Amplifon currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMFPF will outperform the market and that investors should add to their positions of Amplifon.
View the latest ratings for AMFPF.

What other companies compete with Amplifon?

Other companies that are similar to Amplifon include Aspen Pharmacare, Hikma Pharmaceuticals, UDG Healthcare, GN Store Nord A/S and DiaSorin. Learn More about companies similar to Amplifon.

How do I contact Amplifon's investor relations team?

Amplifon's physical mailing address is Via Ripamonti 133, Milan L6, 20141. The company's listed phone number is (390) 257-4721 and its investor relations email address is [email protected] The official website for Amplifon is corporate.amplifon.com. Learn More about contacing Amplifon investor relations.